YORDOVI Trademark

Trademark Overview


On Friday, December 10, 2021, a trademark application was filed for YORDOVI with the United States Patent and Trademark Office. The USPTO has given the YORDOVI trademark a serial number of 97166827. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, March 28, 2024. This trademark is owned by Allarity Therapeutics, Inc.. The YORDOVI trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for the treatment of cancer and medical and veterinary preparations in the nature of anti-cancer preparations; Diagnostic preparations for medical purposes, namely, diagnostic preparations for clinical or medical laboratory use in the field of cancer; diagnostic preparations for medical purposes, namely, to aid in selecting cancer therapies

Diagnostic preparations for scientific or research use; diagnostic preparations other than for medical or veterinary purposes; diagnostic reagents for scientific or research use in the field of cancer

Medical services; medical diagnostic, testing, and reporting services in the field of cancer; providing medical testing and reporting services for diagnostic or treatment purposes in the field of cancer

Providing medical testing services and information in the field of cancer research and disease classification; laboratory research services in the field of cancer; scientific research for medical purposes in the field of cancer
yordovi

General Information


Serial Number97166827
Word MarkYORDOVI
Filing DateFriday, December 10, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, March 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of cancer and medical and veterinary preparations in the nature of anti-cancer preparations; Diagnostic preparations for medical purposes, namely, diagnostic preparations for clinical or medical laboratory use in the field of cancer; diagnostic preparations for medical purposes, namely, to aid in selecting cancer therapies
Goods and ServicesDiagnostic preparations for scientific or research use; diagnostic preparations other than for medical or veterinary purposes; diagnostic reagents for scientific or research use in the field of cancer
Goods and ServicesMedical services; medical diagnostic, testing, and reporting services in the field of cancer; providing medical testing and reporting services for diagnostic or treatment purposes in the field of cancer
Goods and ServicesProviding medical testing services and information in the field of cancer research and disease classification; laboratory research services in the field of cancer; scientific research for medical purposes in the field of cancer

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAllarity Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameAllarity Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2024SOU EXTENSION 1 GRANTED
Thursday, March 28, 2024SOU EXTENSION 1 FILED
Thursday, March 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 29, 2023ASSIGNED TO LIE
Friday, March 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2022NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, September 20, 2022EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, September 20, 2022COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, September 20, 2022EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, September 19, 2022ASSIGNED TO EXAMINER
Wednesday, January 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED